The Low Carb Program for people with type 2 diabetes and pre-diabetes: a mixed methods feasibility study of signposting from general practice.

Autor:	Scott E; Warwick Medical School, Coventry, UK., Shehata M; Warwick Medical School, Coventry, UK., Panesar A; DDM Health, Coventry, UK., Summers C; DDM Health, Coventry, UK charlotte@ddm.health., Dale J; Warwick Medical School, Coventry, UK.
Jazyk:	angličtina
Zdroj:	BJGP open [BJGP Open] 2022 Mar 22; Vol. 6 (1). Date of Electronic Publication: 2022 Mar 22 (Print Publication: 2022).
DOI:	10.3399/BJGPO.2021.0137
Abstrakt:	Background: Evidence shows type 2 diabetes mellitus (T2DM) can be effectively treated with a reduced-carbohydrate diet to support weight loss. Digital apps are increasingly used to support weight loss, yet little is known about their use as part of general practice diabetes care. Aim: Determine the feasibility of signposting from routine NHS general practice to a digital weight management tool (Low Carb Program) for patients with T2DM and pre-diabetes. Design & Setting: Mixed-methods feasibility study implemented within routine general practice consultations at four practices in the Midlands, England. Method: General practices offered signposting to eligible patients attending consultations of any type during a 4-week recruitment period. Rates of offering and accepting signposting were recorded, with program registration, program completion, and self-reported health outcomes (weight, haemoglobin A1C [HbA1c]). Results: Signposting was offered to 351 patients; 160 (45.6%) accepted, 103 (29.3%) registered with the intervention and 43 (26.9% of patients accepting signposting) completed the programme. GPs reported that signposting added between 1-4 minutes to the consultation length. Patients completing the programme reported greater weight loss (7.2kg versus 1.6kg, P <0.001) and HbA1c improvements (-9.1mmol/mol versus 1.7mmol/mol, P <0.001) compared to those who did not, and were more likely to reduce the number of prescribed diabetes medications in general practice. Conclusions: Signposting from real-world general practice to the Low Carb Program is feasible and can potentially improve diabetes outcomes. Further research should explore whether the process of signposting can be enhanced to increase registration, identify whether additional practice-led support leads to increased programme completion, and confirm the intervention's clinical and cost-effectiveness. (Copyright © 2021, The Authors.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu